Performance
All

-7.93%2026
2026
11.38%2025
2025
65.84%2024
2024
80.72%2023
2023
-58.01%2022
2022
-0.60%2021
2021
42.56%2020
2020
80.7%0%-80.7%
Tomas Bagin
📊 Company Analysis – Pfizer ($PFE (Pfizer)) Dear investors, Today I would like to briefly look at Pfizer ($PFE), one of the largest pharmaceutical companies in the world and a stock that has been under pressure in recent years. Pfizer experienced extraordinary growth during the COVID-19 pandemic... Show More
Tomas Bagin
Portfolio Update – Increasing Microsoft Position ($MSFT (Microsoft)) Dear investors, Recently I opened a new position in Microsoft ($MSFT) and decided to increase it further during the recent market correction. After the additional purchase, Microsoft now represents 5.29% of my portfolio. Microsoft... Show More
Tomas Bagin
Dear investors, I have added a new position to the portfolio: $MSFT (Microsoft) . I used the recent correction of approximately -26.5% from its peak as an opportunity to initiate a position. Despite the price decline, Microsoft’s fundamentals remain strong: • Revenue (TTM): ~ $230B+ • Net income... Show More
undefined logo
MSFT
Microsoft
395.39
-6.31 (-1.57%)
Tomas Bagin
Vážení investori, Január pre moje portfólio uzavrel na -1,31 %. Zatiaľ čo index S&P 500 sa naďalej obchoduje v blízkosti svojich nedávnych maxím, trh s kryptomenami zostáva pod tlakom. Táto divergencia vysvetľuje krátkodobú slabšiu výkonnosť. Súčasná korekcia kryptomien však nie je nezvyčajná. Historicky... Show More Translate
Tomas Bagin
2026 Outlook – Long-Term Focus In 2026, I will continue focusing on fundamentally strong, undervalued companies with an emphasis on risk management, cash flow and long-term value. The market remains expensive in many areas, so I prefer patience over chasing trends. My goal is to build positions gradually,... Show More
Tomas Bagin
Dear copiers and investors, The portfolio closed 2025 with a +11.38% return. Considering the volatility in crypto markets and the sharp Bitcoin correction in November, I see this as a solid and respectable result. The equity part of the portfolio performed well and helped balance the drawdown in digital... Show More
Tomas Bagin
Dear investors and copiers, Wishing you a healthy and successful start to 2026. Thank you for the trust, support, and patience throughout 2025 — a year that reminded us how important discipline and long-term thinking really are. I remain focused on sustainable growth, diversification, and risk management... Show More
Tomas Bagin
Dear copiers and investors - November Portfolio Update November closed with a -10.96% portfolio return. This drawdown was almost entirely driven by cryptocurrencies, mainly due to a sharp correction in Bitcoin. The equity part of the portfolio remained relatively stable, without significant losses. For... Show More
Tomas Bagin
I’ve updated my profile to better reflect my long-term strategy and realistic expectations. I believe transparency matters
Tomas Bagin
📊 Company Analysis – LyondellBasell (LYB) At first glance, LyondellBasell looks extremely attractive for income-focused investors. However, it’s important to understand why the numbers look so good — and what risks come with them. 🔹 Annual dividend: $5.48 per share 🔹 Current dividend yield: ~12.7% This... Show More

About Tomas Bagin
Slovakia
Strategy: Value

Long-term investor focused on quality stocks & crypto with disciplined risk management
Show Full Bio
44 Copiers
1.6K Followers